Dominic Marasco
CIK 2053897 · Pres, Endocrine Business Unit · last filed 2026-07-17
Dominic Marasco is a Pres, Endocrine Business Unit who has filed 5 SEC Form 4 insider transactions across 1 company since 2025. The most recent filing shows the insider had shares withheld for taxes covering $14.8K of MNKD on Jul 17, 2026. Current disclosed insider exposure totals $1.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.39M
1
5
$0
Filer Profile
DANBURY, CT 06810
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MNKD | Pres, Endocrine Business Unit | 343,398 | $4.06 | $1.39M | $0 | 5 | 2026-07-17 |
Recent Filings
5 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-17 | MNKD | Tax (F) | −3,623 | -$14.8K | EDGAR |
| 2026-05-22 | MNKD | Grant (A) | +8,474 | $25.0K | EDGAR |
| 2025-06-25 | MNKD | Grant (A) | — | $0 | EDGAR |
| 2025-05-16 | MNKD | Grant (A) | +81,429 | $100.0K | EDGAR |
| 2025-02-13 | MNKD | Grant (A) | +252,000 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.